The webinar “ What can plug-and-play offer large-scale AAV manufacturing?” will be held on Tuesday, March 22 nd, 2022, at 9:00 am PDT/5:00 pm CET. It will be led by Margherita Neri, Manager of Upstream Vector Development at AGC Biologics, and Claire Wartel, Director of Quality and Compliance, Polyplus-Transfection. We have partnered with Polyplus to develop our AAV manufacturing platform, and this will be a follow-up discussion to our 2021 webinar reviewing the results of our work.
Webinar: What can plug-and-play offer large-scale AAV manufacturing?
by Matteo Pellegrino Published on 3/16/22 7:34 AM Thought Leadership, Cell & Gene Therapy
The webinar “ What can plug-and-play offer large-scale AAV manufacturing?” will be held on Tuesday, March 22 nd, 2022, at 9:00 am PDT/5:00 pm CET. It will be led by Margherita Neri, Manager of Upstream Vector Development at AGC Biologics, and Claire Wartel, Director of Quality and Compliance, Polyplus-Transfection. We have partnered with Polyplus to develop our AAV manufacturing platform, and this will be a follow-up discussion to our 2021 webinar reviewing the results of our work.
AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space
by AGC Biologics Events, Thought Leadership, Cell & Gene Therapy, AAV vector manufacturing
AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021
by Matteo Pellegrino Events, Cell & Gene Therapy, Virtual Site Tour
Webinar: Large-Scale AAV Manufacturing: The Road from Concept to Ready-to-Use Platform
by Matteo Pellegrino Published on 5/20/21 7:30 AM Thought Leadership, Cell & Gene Therapy
On-Demand Webinar: Large-Scale LVV Production: Industry-Leading Process Development to High Quality GMP Vector
by David Self Published on 2/25/21 12:00 PM Thought Leadership, Cell & Gene Therapy
The on-demand webinar and Q&A “Large-Scale LVV Production: From Industry-Leading Process Development to High Quality GMP Vector,” with our own Giuliana Vallanti, Director of Development and Global R&D, Cell and Gene Therapy, and the panel of co-hosts is now available to watch for free.
On-Demand Roundtable: Streaming and Optimizing Viral Vector Bioprocess and Analytical Development
by David Self Published on 1/15/21 10:38 AM Thought Leadership, Cell & Gene Therapy
Join AGC Biologics' own Mark Womack, Chief Business Officer and Ramin Baghirzade, Sr. Director and Global Cell and Gene Therapy (C>) Business Development, and a panel of co-hosts for an on-demand presentation of the C> Expert Roundtable on Streaming and Optimizing Viral Vector Bioprocess and Analytical Development, presented by BioInsights.
Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy
by David Self Events, Thought Leadership, Cell & Gene Therapy
Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020.
Article: Process Development: How to Win the Race in Cell & Gene Therapy
by David Self Published on 10/6/20 11:24 AM Thought Leadership, Cell & Gene Therapy
In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.